Health Care

Everything You Need to Know About Brooks Laboratories Limited(NSE:BROOKS)| Stock UP 30% in 2 Months

● Nov 20, 2022

Brooks Laboratories Limited(NSE:BROOKS) has an industry presence of nearly two decades now, leading to established relationships with the customers as...

Infographic : Brooks Labrotories (NSE : BROOKS) | Q4FY22 Results Released! | Revenue UP 94.55% YoY

● Nov 18, 2022

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara...

Infographic : Brooks Labrotories (NSE : BROOKS) | Q1 Results Released! | Revenue DOWN 23.21% YoY

● Nov 18, 2022

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara...

JB Chemicals & Pharmaceuticals Limited Q2 FY23 Earnings Conference Call Insights

● Nov 17, 2022

Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Management Update: [00:06:28] JBCHEPHARM said that in...

Biocon Limited Q2 FY23 Earnings Conference Call Insights

● Nov 16, 2022

Key highlights from Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Q&A Highlights: [00:23:49] Prakash Agarwal of Axis Capital asked about...

IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q2 FY23 Earnings Concall Transcript

● Nov 15, 2022

IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Sanjay Chaturvedi — Executive Director and...

FDC Ltd (FDC) Q2 FY23 Earnings Concall Transcript

● Nov 15, 2022

FDC Ltd (NSE:FDC) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Varsharani Katre — Company Secretary and Compliance Officer Sanjay Jain — Chief Financial...

Aarti Industries Ltd (AARTIIND) Q2 FY23 Earnings Concall Transcript

● Nov 15, 2022

Aarti Industries Ltd (NSE:AARTIIND) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Rajendra V. Gogri — Chairman and...

Aurobindo Pharma Q2FY23; 41% Fall in Profits

● Nov 14, 2022

Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing...

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Transcript

● Nov 14, 2022

JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Jason D’Souza — Vice President of Investor Relations...